Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

Share Price is delayed by 15 minutes
Get Live Data
26.45    0.55 (2.12%)
Bid:
26.00
Ask:
26.90
Spread: 0.90 (3.462%)
Market Cap: £111.44m
EKF Live PriceLast checked at - London Stock Exchange

Intraday Ekf Diagnostics Share Chart

IBL

19 Sep 2006 07:00

Embargoed: 0700hrs 19thSeptember 2006 INTERNATIONAL BRAND LICENSING PLC EXTENDS ADMIRAL DISTRIBUTION IN CENTRAL EUROPE International Brand Licensing Plc ("IBL") announces the appointment of Praguebased World Brands s.r.o. ("World Brands") as the Admiral licensee for theCzech Republic, Slovenia, and Hungary. The licence agreement is based on apre-agreed level of royalties of World Brands' sales revenues over the fiveyear agreement and is subject to minimum guarantees per annum.IBL Chief Executive, Tony Hutchinson, comments: "We are delighted to havesigned the agreement with World Brands that will see Admiral launched in thisnew territory for the first time. World Brands has a wealth of experience bothwith the sports retail sector and the professional sporting federations of theregion, and we are confident that Admiral will quickly develop a real presencein these emerging markets."Admiral is the sponsor of the England and West Indies cricket teams togetherwith Leeds United Football Club.For further information contact:International Brand Licensing PlcTony Hutchinson: 0041 794 689450Adam Reynolds: 020 7823 1733ENDINTERNATIONAL BRAND LICENSING PLC
Date   Source Headline
29th Jan 20257:00 amRNSFY 2024 Trading Update
17th Sep 20247:00 amRNSHalf-year Report
3rd Sep 20247:00 amRNSNotice of Results and Investor Presentation
24th Jul 20247:00 amRNSTrading Update
14th May 20241:15 pmRNSResult of AGM and Voting Results
14th May 202410:17 amRNSAGM Statement & Positive Q1 update (replacement)
14th May 20247:00 amRNSAGM Statement & Positive Q1 Trading update
22nd Apr 202411:53 amRNSPosting of Annual Report & Notice of AGM
25th Mar 20245:15 pmRNSDirector/PDMR Shareholding
20th Mar 20248:30 amRNSFinal Results
15th Mar 20247:00 amRNSInvestor Presentation – Revised start time
11th Mar 20247:00 amRNSNotice of Results and Investor Presentation
29th Jan 20247:00 amRNSTrading Update
11th Jan 20247:00 amRNSDirector/PDMR Shareholding
3rd Jan 20244:14 pmRNSHolding(s) in Company
29th Nov 20234:55 pmRNSHolding(s) in Company
26th Oct 20237:00 amRNSOpening of new US LS Manufacturing Facility
26th Sep 20237:00 amRNSInterim results
14th Sep 20237:00 amRNSNotice of Results & Investor Presentation
12th Sep 20237:01 amRNSTrading Update
12th Sep 20237:00 amRNSAppointment of CFO
26th Jul 20237:00 amRNSTrading Update
28th Jun 20237:00 amRNSDirectorate Change
20th Jun 20237:00 amRNSEnzyme fermentation capacity expansion progress
1st Jun 202311:07 amRNSHolding(s) in Company
24th May 20237:01 amRNSUpdate re. EKF distribution of shares in Verici Dx
24th May 20237:00 amRNSDistribution of shares in Verici Dx plc
22nd May 20232:52 pmRNSHolding(s) in Company
17th May 202311:50 amRNSResult of AGM and Voting Results
17th May 20237:00 amRNSAGM Statement
3rd May 20237:00 amRNSSuccessful quality management audits
25th Apr 20234:10 pmRNSTotal Voting Rights
21st Apr 20232:30 pmRNSPosting of Annual Report & Notice of AGM
28th Mar 20237:00 amRNSFinal Results
23rd Mar 20237:00 amRNSDisposal of ADL Health
1st Mar 20237:00 amRNSNotice of Results and Investor Presentation
21st Feb 20233:31 pmRNSHolding(s) in Company
10th Feb 20233:12 pmRNSHolding(s) in Company
6th Feb 20237:00 amRNSTrading update
9th Jan 20237:00 amRNSChange of Adviser
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
22nd Dec 20227:00 amRNSPoint-of-Care update
15th Dec 20224:52 pmRNSHolding(s) in Company
14th Dec 20224:32 pmRNSHolding(s) in Company
6th Dec 20225:30 pmRNSHolding(s) in Company
14th Nov 20225:52 pmRNSHolding(s) in Company
20th Sep 20227:01 amRNSDividend Timetable
20th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.